Clinical Trial Details

Trial ID: L0922
Source ID: IRCT2013021012421N1
Associated Drug: Metformin
Title: The evaluation of the effect of vitamin E and metformin on fatty liver in obese children
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non alcoholic fatty liver. <br>fatty (change of) liver, not elsewhere classified;fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: Metformin 500mg tab bd. Intervention 2: Metformin 500mg tab tds. Intervention 3: vitamin E 400 unit pearl daily. Intervention 4: vitamin E 400 unit pearl bd.;Treatment - Drugs;Treatment - Drugs;Treatment - Drugs;Treatment - Drugs;Metformin
Outcome Measures: Liver ecogenicity. Timepoint: before and 2 months after the intervention and end of intervention (four months after intervention). Method of measurement: sonography.BMI. Timepoint: before and 2 months after the intervention and end of intervention (four months after intervention). Method of measurement: balance and height messuring instruments.
Sponsor/Collaborators: Vice chancellor for research, Kashan University of Medical Sciences and Health Services
Gender: All
Age: 4 years18 years
Phases: Phase 2
Enrollment: 104
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 05/05/2013
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/12479